• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

High Dose to save the day

anonymous

Guest
Great data presented to take back the market. We won’t lose Trulicity scripts to Ozempic now that we basically match A1c and are right there in weight loss.

Preferred device, better covered and same clinical profile. That’s a win for us!!!
 










Except Novo is finishing results of 1mg vs 2mg of Ozempic. It’s an efficacy horse race and they will steal MS like they always do. Like they’re already doing with oral.
 








So you're excited that you have to triple the maximum dosage of Trulicity, and it still doesn't match the A1C and weight loss of standard 1mg Ozempic?
And still no titration, right? I know you like to talk about that...